Association of Physical Activity With Bioactive Lipids and Cardiovascular Events

Background: To clarify the mechanisms underlying physical activity (PA)-related cardioprotection, we examined the association of PA with plasma bioactive lipids (BALs) and cardiovascular disease (CVD) events. We additionally performed genome-wide associations. Methods: PA-bioactive lipid associations were examined in VITAL (VITamin D and OmegA-3 TriaL)-clinical translational science center (REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01169259; N=1032) and validated in JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)-NC (REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00239681; N=589), using linear models adjusted for age, sex, race, low-density lipoprotein-cholesterol, total-C, and smoking. Significant BALs were carried over to examine associations with incident CVD in 2 nested CVD case-control studies: VITAL-CVD (741 case-control pairs) and JUPITER-CVD (415 case-control pairs; validation). Results: We detected 145 PA-bioactive lipid validated associations (false discovery rate <0.1). Annotations were found for 6 of these BALs: 12,13-diHOME, 9,10-diHOME, lysoPC(15:0), oxymorphone-3b-D-glucuronide, cortisone, and oleoyl-glycerol. Genetic analysis within JUPITER-NC showed associations of 32 PA-related BALs with 22 single-nucleotide polymorphisms. From PA-related BALs, 12 are associated with CVD. Conclusions: We identified a PA-related bioactive lipidome profile out of which 12 BALs also had opposite associations with incident CVD events.

[1]  T. Spector,et al.  Metabolome Genome-Wide Association Study Identifies 74 Novel Genomic Regions Influencing Plasma Metabolites Levels , 2022, Metabolites.

[2]  J. Danesh,et al.  A cross-platform approach identifies genetic regulators of human metabolism and health , 2021, Nature Genetics.

[3]  J. Danesh,et al.  Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci , 2020, BMC Medicine.

[4]  M. Buman,et al.  World Health Organization 2020 guidelines on physical activity and sedentary behaviour , 2020, British Journal of Sports Medicine.

[5]  Olga V. Demler,et al.  One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL) , 2020, Metabolites.

[6]  M. Kelly,et al.  Metabolomics, Physical Activity, Exercise and Health: a Review of the Current Evidence. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[7]  N. Lemoine,et al.  SNPnexus: a web server for functional annotation of human genome sequence variation (2020 update) , 2020, Nucleic Acids Res..

[8]  F. Kronenberg,et al.  Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans , 2020, Nature Genetics.

[9]  Stepán Kouril,et al.  CROP: correlation-based reduction of feature multiplicities in untargeted metabolomic data , 2020, Bioinform..

[10]  Unraveling the steroid hormone response in male marathon runners: Correlation of running time with aldosterone and progesterone , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  J. Manson,et al.  Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults. , 2019, Clinical chemistry.

[12]  W. Willett,et al.  Metabolome-wide Association Study with Habitual Physical Activity in Four Prospective Cohort Studies. , 2019, American journal of epidemiology.

[13]  S. Usanov,et al.  Ligand-binding properties and catalytic activity of the purified human 24-hydroxycholesterol 7α-hydroxylase, CYP39A1 , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  Pietro Della Briotta Parolo,et al.  Genetic architecture of human plasma lipidome and its link to cardiovascular disease , 2019, Nature Communications.

[15]  T. Spector,et al.  Genome-wide scan identifies novel genetic loci regulating salivary metabolite levels , 2019, bioRxiv.

[16]  A. Russell,et al.  Intramuscular inflammatory and resolving lipid profile responses to an acute bout of resistance exercise in men , 2019, Physiological reports.

[17]  J. Manson,et al.  Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease , 2019, The New England journal of medicine.

[18]  Laurel M. Wentz,et al.  The compelling link between physical activity and the body's defense system , 2018, Journal of sport and health science.

[19]  Mir Henglin,et al.  Directed Non-Targeted Mass Spectrometry and Chemical Networking for Discovery of Eicosanoids , 2018, 1806.01467.

[20]  C. Gieger,et al.  A network-based conditional genetic association analysis of the human metabolome , 2018, GigaScience.

[21]  Y. Tseng,et al.  12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. , 2018, Cell metabolism.

[22]  K. Kamiński,et al.  LC–MS‐based serum fingerprinting reveals significant dysregulation of phospholipids in chronic heart failure , 2018, Journal of pharmaceutical and biomedical analysis.

[23]  R. Gibbs,et al.  Sequence-Based Analysis of Lipid-Related Metabolites in a Multiethnic Study , 2018, Genetics.

[24]  Nichole Bynum,et al.  Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS. , 2018, Journal of analytical toxicology.

[25]  Valerio Chiurchiù,et al.  Bioactive Lipids and Chronic Inflammation: Managing the Fire Within , 2018, Front. Immunol..

[26]  J. Kals,et al.  Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[27]  J. Mezey,et al.  Whole-exome sequencing identifies common and rare variant metabolic QTLs in a Middle Eastern population , 2018, Nature Communications.

[28]  M. Blüher,et al.  The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue , 2017, Nature Medicine.

[29]  Amalio Telenti,et al.  Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites , 2017, Nature Genetics.

[30]  B. Paulweber,et al.  Specific circulating phospholipids, acylcarnitines, amino acids and biogenic amines are aerobic exercise markers. , 2017, Journal of science and medicine in sport.

[31]  C. Matthews,et al.  Objectively measured physical activity and plasma metabolomics in the Shanghai Physical Activity Study. , 2016, International journal of epidemiology.

[32]  M. Spite,et al.  Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology. , 2016, Circulation research.

[33]  T. Spector,et al.  Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms , 2016, PloS one.

[34]  J. Manson,et al.  Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL). , 2016, Contemporary clinical trials.

[35]  J. Markworth,et al.  Emerging roles of pro-resolving lipid mediators in immunological and adaptive responses to exercise-induced muscle injury. , 2016, Exercise immunology review.

[36]  J. Nadolski,et al.  Salivary but not plasma cortisone tracks the plasma cortisol response to exercise: effect of time of day , 2016, Journal of Endocrinological Investigation.

[37]  E. Boerwinkle,et al.  Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study , 2015, PloS one.

[38]  C. Gieger,et al.  Metabolomic Identification of a Novel Pathway of Blood Pressure Regulation Involving Hexadecanedioate , 2015, Hypertension.

[39]  Claude Bouchard,et al.  Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits. , 2015, Cell metabolism.

[40]  R. Lehmann,et al.  Metabolic profiles during an oral glucose tolerance test in pregnant women with and without gestational diabetes. , 2015, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[41]  Christian Gieger,et al.  Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels , 2015, Nature Communications.

[42]  Yijiang Zhou,et al.  Association of two polymorphisms in the FADS1/FADS2 gene cluster and the risk of coronary artery disease and ischemic stroke. , 2015, International journal of clinical and experimental pathology.

[43]  S. Popov,et al.  Exercise and NO production: relevance and implications in the cardiopulmonary system , 2015, Front. Cell Dev. Biol..

[44]  M. Fischer,et al.  Alterations of Plasma Lysophosphatidylcholine Species in Obesity and Weight Loss , 2014, PloS one.

[45]  M. Meaney,et al.  Metabolomics approach to assessing plasma 13- and 9-hydroxy-octadecadienoic acid and linoleic acid metabolite responses to 75-km cycling. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[46]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[47]  T. Spector,et al.  Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study , 2014, Circulation.

[48]  B. Notario-Pacheco,et al.  Obesity as a Mediator of the Influence of Cardiorespiratory Fitness on Cardiometabolic Risk: A Mediation Analysis , 2014, Diabetes Care.

[49]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[50]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[51]  Ming-Huei Chen,et al.  A genome-wide association study of the human metabolome in a community-based cohort. , 2013, Cell metabolism.

[52]  Y. Pawitan,et al.  A Genome‐Wide Assessment of Variability in Human Serum Metabolism , 2013, Human mutation.

[53]  Linda Valeri,et al.  Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. , 2013, Psychological methods.

[54]  Christian Gieger,et al.  Mining the Unknown: A Systems Approach to Metabolite Identification Combining Genetic and Metabolic Information , 2012, PLoS genetics.

[55]  J. Mcgiff,et al.  The red blood cell participates in regulation of the circulation by producing and releasing epoxyeicosatrienoic acids. , 2012, Prostaglandins & other lipid mediators.

[56]  P. Ridker,et al.  Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial , 2012, Circulation. Cardiovascular genetics.

[57]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[58]  Yurii S. Aulchenko,et al.  Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations , 2012, PLoS genetics.

[59]  P. Toth.  On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy: JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) , 2012 .

[60]  SiddharthPrakash.  Human Metabolic Individuality in Biomedical and Pharmaceutical Research , 2011 .

[61]  I. Haviv,et al.  Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[62]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[63]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[64]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[65]  G. Schmitz,et al.  Metabolism and atherogenic disease association of lysophosphatidylcholine. , 2010, Atherosclerosis.

[66]  G. Ginsburg,et al.  The SLCO1B1*5 genetic variant is associated with statin-induced side effects. , 2009, Journal of the American College of Cardiology.

[67]  D. Göpfertová.  Department of Epidemiology , 2009 .

[68]  J. Miners,et al.  Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase* , 2008, Journal of Biological Chemistry.

[69]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[70]  Christian Gieger,et al.  Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum , 2008, PLoS genetics.

[71]  Eden R Martin,et al.  A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms , 2008, Genetic epidemiology.

[72]  Samia Mora,et al.  Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms , 2007, Circulation.

[73]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[74]  D. Thompson,et al.  Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst , 2007, Journal of Biosciences.

[75]  Y. Benjamini,et al.  Adaptive linear step-up procedures that control the false discovery rate , 2006 .

[76]  N. Aiyar,et al.  Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells , 2006, Molecular and Cellular Biochemistry.

[77]  E. Prommer.  Oxymorphone: a review , 2006, Supportive Care in Cancer.

[78]  P. Delamarche,et al.  Overnight urinary cortisol and cortisone add new insights into adaptation to training. , 2005, Medicine and science in sports and exercise.

[79]  B E Ainsworth,et al.  Compendium of physical activities: an update of activity codes and MET intensities. , 2000, Medicine and science in sports and exercise.

[80]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[81]  H. Vapaatalo,et al.  Effects of catecholamines on eicosanoid synthesis with special reference to prostanoid/leukotriene ratio. , 1992, Free radical biology & medicine.

[82]  J. Lucy,et al.  Membrane proteins in human erythrocytes during cell fusion induced by oleoylglycerol. , 1978, The Biochemical journal.

[83]  Robert I. Jennrich,et al.  An Asymptotic χ2 Test for the Equality of Two Correlation Matrices , 1970 .